However, a high proportion (15%) of patients with a biochemical diagnosis of OTC deficiency do not carry a mutation in the OTC gene identifiable by conventional methods [5,7], suggesting that the remaining alleles may correspond to mutations localized in the promoter or deep intronic regions, or are due to locus heterogeneity [8]. Here, OTC is linked to ornithine carbamoyltransferase deficiency.